Essential Oils: Antifungal activity and study methods

Abstract

Essential oils (EOs) are natural, volatile compounds extracted from plants, known for their diverse biological properties, including potent antifungal activity. This review explores the antifungal mechanisms of EOs, their efficacy against human and plant fungal pathogens, and their applications in medicine, agriculture and food preservation. EOs disrupt fungal cell membranes, inhibit ergosterol biosynthesis, induce oxidative stress and interfere with mitochondrial function and enzymatic pathways, leading to fungal cell death. Their broad-spectrum activity makes them promising alternatives to conventional antifungals, particularly in the face of rising antifungal resistance. Synergistic effects with conventional drugs, such as azoles and polyenes, further enhance their therapeutic potential. However, challenges such as variability in composition, stability, sensory impact and regulatory hurdles limit their widespread adoption. Advanced delivery systems, including nano-encapsulation and emulsification, are being explored to improve EO stability and efficacy. In agriculture, EOs show promise as biocontrol agents against crop pathogens, while in food preservation, they inhibit spoilage fungi and extend shelf life. Future research should focus on optimizing EO formulations, conducting in vivo and clinical studies, and developing regulatory frameworks to facilitate their integration into mainstream applications. By addressing these challenges, EOs can emerge as safe, sustainable and effective antifungal agents, offering innovative solutions across multiple industries.

Keywords: Antifungal activities, essential oils, study methods

INTRODUCTION

Essential oils (EOs) are natural, volatile and aromatic compounds extracted from various plant parts, including leaves, flowers, stems, roots and seeds. They are primarily obtained through steam distillation or cold pressing; two methods that help preserve the integrity of their bioactive constituents.

These oils are known for their distinctive fragrances, which are often used in perfumery and aromatherapy, as well as for their diverse biological properties, including antimicrobial, antioxidant, anti-inflammatory and antifungal activities. Due to their complex chemical composition, essential oils have played a significant role in traditional medicine across different cultures for centuries, being utilized for wound healing, respiratory ailments and skin infections (Bakkali et al., 2008).

Among the many pharmacological properties of essential oils, their antimicrobial potential, particularly their antifungal activity, has attracted considerable scientific interest. Fungal infections remain a significant challenge in both clinical and agricultural settings, impacting human and animal health, as well as food security.

In medical fields, pathogenic fungi such as Candida spp., Aspergillus spp. and Cryptococcus spp. are responsible for opportunistic infections, particularly in immuno-compromised individuals, often leading to high morbidity and mortality rates (Kumar et al., 2016). In agriculture, fungal pathogens such as Fusarium, Botrytis and Phytophthora cause substantial crop losses, resulting in economic burdens and food shortages worldwide (Tripathi and Dubey, 2004). Additionally, post-harvest fungal contamination contributes to food spoilage and mycotoxin production, posing serious risks to public health (Kumar and Shukla, 2018).

Conventional antifungal treatments, including azoles, polyenes and echinocandins, have been widely used to combat fungal infections. However, the increasing emergence of antifungal resistance, coupled with concerns regarding drug toxicity and environmental impact, underscores the need for alternative solutions (Perlin et al., 2017).

Essential oils have gained attention as potential natural antifungal agents due to their broad-spectrum activity, biodegradability and lower propensity for resistance development. Their antifungal efficacy is largely attributed to their diverse chemical constituents, such as terpenes (e.g., thymol, carvacrol), phenolics (e.g., eugenol, cinnamaldehyde) and aldehydes, which interact with fungal membranes, metabolic pathways and cellular machinery, ultimately leading to fungal growth inhibition or cell death (Hyldgaard et al., 2012; Nazzaro et al., 2013).

Despite their promising potential, the application of essential oils in antifungal therapy faces several challenges, including variability in chemical composition, stability, solubility and formulation issues. Factors such as plant origin, extraction method and environmental conditions can influence the composition and potency of essential oils, leading to inconsistencies in their antifungal efficacy.

Additionally, their hydrophobic nature limits their direct application in aqueous environments, necessitating the development of novel delivery systems such as nanoemulsions, encapsulation techniques and polymer-based carriers to enhance their solubility, stability and controlled release (Sharifi-Rad et al., 2020).

This review aims to provide a comprehensive analysis of the antifungal mechanisms of essential oils, their effectiveness against various fungal pathogens and their potential applications in medicine, agriculture and food preservation. By exploring recent research and advancements, we seek to highlight both the opportunities and challenges in leveraging essential oils as natural antifungal agents.

Understanding their mode of action, efficacy and formulation strategies will be essential in unlocking their full potential as safe, sustainable and effective alternatives to synthetic antifungal compounds.

ANTIFUNGAL MECHANISMS OF ESSENTIAL OILS

The antifungal properties of essential oils (EOs) are primarily attributed to their complex chemical composition, which includes a diverse array of bioactive compounds such as terpenes, phenols, alcohols, aldehydes and ketones. These constituents interact with fungal cells through multiple mechanisms, ultimately leading to cell dysfunction and death. The effectiveness of essential oils against fungal pathogens has gained considerable attention due to their potential as natural antifungal agents, offering alternatives to conventional synthetic fungicides while reducing the risk of resistance development (Bakkali et al., 2008).

Disruption of Fungal Cell Membrane Integrity

A key antifungal mechanism of essential oils (EOs) is their ability to disrupt fungal cell membrane integrity, leading to increased permeability, leakage of intracellular components, ion imbalance and eventual cell death. This effect is primarily attributed to the lipophilic nature of EO constituents, particularly terpenoids, phenols and aldehydes, which integrate into the phospholipid bilayer of fungal membranes and alter membrane fluidity (Hyldgaard et al., 2012).

Mechanism of Membrane Disruption

Several essential oil compounds, including thymol, carvacrol, geraniol and eugenol, exhibit strong hydrophobic interactions with fungal membranes, leading to:

• Membrane fluidization – Disrupting the ordered structure of phospholipids, making the membrane more permeable.

• Alteration of lipid composition – Interfering with ergosterol, a key fungal membrane sterol, reducing its stability (Tian et al., 2012).

• Cytoplasmic leakage – Causing the efflux of essential intracellular molecules such as ions, ATP and nucleotides, ultimately leading to fungal cell lysis.

Several studies have confirmed the membrane-disrupting effects of essential oils on fungal pathogens (Table 1).

Role of Ergosterol Targeting

Fungal membranes rely on ergosterol for structural integrity and function, much like cholesterol in mammalian cells. Many EO components inhibit ergosterol biosynthesis, further weakening fungal membranes:

• Cinnamaldehyde (from cinnamon oil) disrupts sterol biosynthesis pathways, making fungal membranes more susceptible to stress and antifungal agents (Pinto et al., 2009).

• Carvacrol and thymol competitively inhibit squalene epoxidase, a key enzyme in ergosterol synthesis, contributing to membrane dysfunction (Zore et al., 2011).

Inhibition of Ergosterol Biosynthesis

Ergosterol is a crucial sterol in fungal cell membranes, playing a key role in maintaining membrane fluidity, structure and function. Several phenolic compounds found in essential oils, such as eugenol (from clove oil) and cinnamaldehyde (from cinnamon oil), interfere with ergosterol biosynthesis, leading to structural defects in fungal membranes (Pinto et al., 2009). Inhibition of ergosterol synthesis weakens the fungal cell membrane, making it more susceptible to environmental stressors and antimicrobial agents. Studies have shown that eugenol can effectively inhibit Candida albicans by depleting ergosterol levels, resulting in increased permeability and impaired membrane function (Shreaz et al., 2016).

Generation of Reactive Oxygen Species (ROS) and Oxidative Stress

Another critical mechanism by which essential oils (EOs) exert antifungal effects is through the induction of oxidative stress. Many EO components, including thymol, eugenol, carvacrol and linalool, stimulate the excessive production of reactive oxygen species (ROS) such as hydrogen peroxide (H₂O₂), superoxide anions (O₂-) and hydroxyl radicals (•OH), leading to oxidative damage in fungal cells (Tian et al., 2012).

ROS are natural byproducts of cellular respiration, but their excessive accumulation leads to oxidative stress, which damages multiple cellular components:

• Lipid Peroxidation – ROS attack polyunsaturated fatty acids in fungal membranes, disrupting membrane integrity and function (Mansour et al., 2020).

• Protein Oxidation – Oxidative stress modifies essential enzymes and structural proteins, impairing cellular metabolism (Bakkali et al., 2008).

• DNA Damage – ROS induce strand breaks and base modifications, leading to mutations and genomic instability in fungal cells (Sharma et al., 2021).

Several studies have demonstrated the ability of essential oils to trigger oxidative stress and fungal cell death (Table 2).

Role of Mitochondrial Dysfunction and Apoptosis

Fungal mitochondria are major targets of EO-induced oxidative stress:

• Increased ROS levels damage mitochondrial membranes, causing a loss of mitochondrial membrane potential (ΔΨm) and impairing ATP production (Zhang et al., 2017).

• Mitochondrial dysfunction triggers the release of pro-apoptotic factors such as cytochrome c, leading to caspase activation and apoptosis (Zore et al., 2011).

• ROS-induced DNA fragmentation further amplifies apoptotic pathways, accelerating fungal cell death (Sharma et al., 2021).

Disruption of Mitochondrial Function

Mitochondria play a fundamental role in fungal energy metabolism, redox balance and cell survival. Essential oils (EOs) and their bioactive compounds can disrupt mitochondrial function through multiple mechanisms, ultimately leading to metabolic dysfunction, ATP depletion and cell death (Kumar et al., 2016).

Inhibition of the Electron Transport Chain (ETC) and ATP Synthesis

The electron transport chain (ETC) in fungal mitochondria is essential for ATP generation via oxidative phosphorylation. Some EO components, such as carvacrol, cinnamaldehyde and eugenol, interfere with the electron flow across ETC complexes, leading to:

• Reduced ATP production – EO-mediated inhibition of complex I (NADH dehydrogenase) and complex III (cytochrome bc1 complex) impairs ATP synthesis (Svetaz et al., 2007).

• Increased ROS production – ETC disruption results in electron leakage, causing excessive reactive oxygen species (ROS) accumulation and oxidative stress (Zore et al., 2011).

• Energy metabolism collapse – Inhibited ATP synthesis compromises active transport, nutrient uptake and cellular homeostasis, leading to fungal cell death (Khan et al., 2017).

For example, studies on Aspergillus flavus and Candida albicans have shown that carvacrol and cinnamaldehyde disrupt mitochondrial respiration, leading to ATP depletion and metabolic failure (Svetaz et al., 2007).

Mitochondrial Membrane Depolarization and Permeability Transition

EOs can induce mitochondrial membrane depolarization, disrupting mitochondrial function and initiating programmed cell death. This occurs through:

• Disruption of mitochondrial membrane potential (ΔΨm) – Loss of electrochemical gradient impairs ATP synthesis and induces mitochondrial dysfunction (Shreaz et al., 2016).

• Mitochondrial permeability transition (MPT) pore opening – Leads to release of pro-apoptotic factors, such as cytochrome c, triggering caspase-dependent apoptosis (Bakkali et al., 2008).

• Collapse of mitochondrial integrity – Altered membrane permeability results in mitochondrial swelling and structural damage (Kumar et al., 2016).

For instance, eugenol and thymol have been reported to induce mitochondrial permeability transition in Cryptococcus neoformans, leading to cell cycle arrest and apoptosis (Tian et al., 2012).

Several studies have provided strong experimental evidence for EO-induced mitochondrial dysfunction in fungi (Table 3).

Interference with Fungal Enzyme Systems

Essential oils (EOs) exert their antifungal activity not only through direct membrane disruption but also by targeting key enzymatic pathways essential for fungal growth, virulence and survival. Many EO constituents, including phenols, aldehydes and terpenoids, act as enzyme inhibitors, impairing crucial metabolic functions and structural integrity in fungal cells.

Fungi rely on hydrolytic enzymes such as proteases, phospholipases and lipases to degrade host tissues, facilitate invasion and establish infection (Ahmad et al., 2010). Several EO components have been shown to inhibit these enzymes, thereby reducing fungal pathogenicity (Table 4).

SYNERGISTIC EFFECTS WITH CONVENTIONAL ANTIFUNGALS

Combining essential oils (EOs) with conventional antifungals has gained attention for enhancing efficacy, reducing resistance and minimizing toxicity. Studies show that EOs synergize with azoles (e.g., fluconazole, itraconazole), polyenes (e.g., amphotericin B) and echinocandins, leading to lower minimum inhibitory concentrations (MICs) and improved fungal eradication rates (Harris, 2002; Biazzi et al., 2020; da Silva et al., 2021; Pina-Vaz et al., 2004).

Synergy with Azoles

Azoles inhibit ergosterol biosynthesis, a key fungal membrane component, but resistance is a growing issue, particularly in Candida and Aspergillus species. EOs enhance azole activity by increasing membrane permeability, improving drug uptake (Khan et al., 2017; Turgis et al., 2012).

• Cinnamaldehyde (cinnamon oil) and carvacrol (oregano, thyme oils) synergize with fluconazole against resistant Candida albicans, enhancing membrane disruption and intracellular drug accumulation (Zore et al., 2011; Khan et al., 2017; Kedia et al., 2014).

• Eugenol (clove oil) inhibits efflux pumps, a major azole resistance mechanism, restoring fluconazole susceptibility (Ahmad et al., 2010; Shreaz et al., 2016; Doke et al., 2014).

Synergy with Polyenes (Amphotericin B and Nystatin)

Polyenes bind ergosterol, forming pores in fungal membranes, but their toxicity limits use (Cavaleiro et al., 2006; Lemos et al., 2017). EOs allow for dose reduction while maintaining efficacy.

• Thymol (thyme oil) enhances amphotericin B-induced membrane disruption, reducing required drug concentrations against Cryptococcus neoformans (Biazzi et al., 2020; da Silva et al., 2021).

• Geraniol (rose, citronella oils) synergizes with nystatin, lowering MICs against Candida spp. by fluidizing membranes (de Castro et al., 2015; Pina-Vaz et al., 2004; Oliveira et al., 2019).

Synergy with Echinocandins (Caspofungin and Micafungin)

Echinocandins inhibit β-1,3-glucan synthase, weakening fungal cell walls. EOs further destabilize these structures, enhancing drug-induced lysis (Mith et al., 2020; Peralta et al., 2018).

• Citral (lemongrass oil) synergizes with caspofungin, increasing cell wall damage in Aspergillus fumigatus (Li et al., 2018; Tian et al., 2012).

• Linalool (lavender oil) with micafungin enhances Candida biofilm inhibition, a major resistance factor (Kim et al., 2019; Oliveira et al., 2019; Turgis et al., 2012).

Mechanisms Underlying EO-Drug Synergy

Proposed mechanisms for EO-antifungal synergy include:

• Increased Membrane Permeability – EOs disrupt fungal membranes, enhancing drug penetration (Khan et al., 2017; Turgis et al., 2012; Oliveira et al., 2019).

• Efflux Pump Inhibition – Compounds like eugenol and thymol block multidrug resistance (MDR) transporters, preventing drug expulsion (Ahmad et al., 2010; Shreaz et al., 2016; Doke et al., 2014).

• Enhanced Oxidative Stress – EOs induce reactive oxygen species (ROS), exacerbating drug-induced damage (Tian et al., 2012; Peralta et al., 2018).

• Cell Wall Disruption – Components such as citral and carvacrol weaken fungal cell walls, improving drug efficacy (Li et al., 2018; Mith et al., 2020; Oliveira et al., 2019).

EFFICACY AGAINST PATHOGENIC FUNGI

Essential oils (EOs) exhibit broad-spectrum antifungal activity against a variety of human and plant pathogenic fungi. Their effectiveness is attributed to their ability to disrupt fungal cell membranes, inhibit spore germination and interfere with key metabolic processes. Due to their multi-targeted mechanisms of action, EOs present a promising alternative to conventional antifungal agents, which are increasingly associated with resistance development and environmental concerns.

Antifungal Activity Against Human Pathogens

One of the most extensively studied essential oils in medical mycology is tea tree oil (Melaleuca alternifolia), which has demonstrated potent activity against Candida albicans, a major opportunistic pathogen responsible for oral, vaginal and systemic candidiasis. The antifungal effects of tea tree oil are largely attributed to its high content of terpinen-4-ol, which disrupts fungal biofilm formation, inhibits hyphal development and alters membrane integrity, leading to increased permeability and cell death (Hammer et al., 2012). Additionally, tea tree oil has shown efficacy against Candida glabrata and Candida parapsilosis, two emerging fungal pathogens with notable resistance to azole antifungals (Pina-Vaz et al., 2004).

Lavender oil (Lavandula angustifolia) is another essential oil with significant antifungal properties, particularly against mold-forming fungi such as Aspergillus flavus and Aspergillus niger. These species are known for producing aflatoxins, potent mycotoxins that contaminate food and pose serious health risks (Zuzarte et al., 2011). Studies have demonstrated that linalool, a major component of lavender oil, disrupts fungal metabolism by interfering with mitochondrial function and ergosterol biosynthesis, thereby inhibiting fungal growth (Schnitzler et al., 2001). Other essential oils, such as those derived from eucalyptus, peppermint and cinnamon, have also demonstrated strong inhibitory effects against dermatophytes (Trichophyton spp., Microsporum spp. and Epidermophyton floccosum), which cause common skin infections like athlete’s foot and ringworm (Park et al., 2007).

Antifungal Activity Against Plant Pathogens

In agricultural settings, essential oils have gained attention as biocontrol agents against a wide range of plant pathogenic fungi, offering a more sustainable alternative to synthetic fungicides. Essential oils derived from thyme (Thymus vulgaris), oregano (Origanum vulgare) and clove (Syzygium aromaticum) have been particularly effective in controlling fungal species that cause severe crop damage.

For example, essential oils rich in thymol and carvacrol, such as those from thyme and oregano, have demonstrated strong antifungal activity against Fusarium spp., which are responsible for devastating diseases like Fusarium wilt and Fusarium head blight in cereal crops (Daferera et al., 2003). These compounds interfere with spore germination, hyphal elongation and enzymatic activity, ultimately reducing fungal colonization on plant tissues (Kouassi et al., 2012).

Botrytis cinerea, the causative agent of gray mold disease, is another major agricultural pathogen controlled by essential oils. This fungus affects a variety of fruits and vegetables, including grapes, strawberries and tomatoes, leading to significant postharvest losses. Essential oils such as cinnamon oil (rich in cinnamaldehyde) and clove oil (rich in eugenol) have been found to effectively inhibit the growth of B. cinerea by disrupting fungal respiration and membrane integrity (Camele et al., 2012).

Additionally, essential oils have been tested for their fumigant properties, with promising results in reducing fungal contamination in stored grains and food products. Lemongrass oil (Cymbopogon citratus) and peppermint oil (Mentha piperita) have demonstrated strong vapor-phase antifungal activity against Aspergillus spp. and Penicillium spp., fungi commonly found in stored grains, nuts and dairy products (Soylu et al., 2010). This makes EOs attractive candidates for natural food preservatives, reducing reliance on synthetic chemical preservatives.

APPLICATIONS IN MEDICINE AND FOOD PRESERVATION

The potent antifungal properties of essential oils (EOs) have led to their exploration in various fields, particularly in medicine and food preservation. Their ability to target fungal pathogens through multiple mechanisms, coupled with their natural origin, biodegradability and low toxicity, makes them attractive alternatives to synthetic antifungal drugs and chemical preservatives.

Medical Applications

Fungal infections pose a significant challenge in clinical settings, affecting the skin, nails, mucosal surfaces and even internal organs. The increasing resistance of fungal pathogens to conventional antifungal drugs, along with concerns over drug toxicity and side effects, has driven interest in essential oils as potential natural antifungal agents.

Essential oils are being investigated as topical treatments for superficial fungal infections such as dermatophytosis (ringworm, athlete’s foot) and onychomycosis (nail fungus). Conventional treatments, such as azoles and terbinafine, often require prolonged use and can lead to drug resistance. Several essential oils, including eucalyptus oil, tea tree oil and clove oil, have demonstrated significant antifungal activity against dermatophytes such as Trichophyton rubrum, Microsporum canis and Epidermophyton floccosum (Soković et al., 2010).

For instance, eucalyptus oil, which contains 1,8-cineole, has shown promise in treating onychomycosis caused by Trichophyton rubrum, with studies indicating its ability to penetrate the nail plate and inhibit fungal growth (Mertas et al., 2015). Similarly, tea tree oil (Melaleuca alternifolia), rich in terpinen-4-ol, has been found to be effective in reducing symptoms of athlete’s foot, with efficacy comparable to clotrimazole, a common antifungal drug (Satchell et al., 2002).

Beyond topical applications, some essential oils have shown promise in systemic antifungal therapy. Research has explored their potential in inhalable formulations, nanoencapsulation and emulsions to enhance their bioavailability and reduce toxicity. Cinnamon oil (rich in cinnamaldehyde) and oregano oil (containing carvacrol and thymol) have exhibited synergistic effects when combined with conventional antifungals like fluconazole and amphotericin B, improving treatment outcomes against Candida spp. and Aspergillus spp. infections (Zore et al., 2011).

Food Preservation Applications

Fungal contamination of food products is a major global issue, leading to spoilage, mycotoxin production and economic losses. Chemical preservatives, such as sorbic acid and benzoates, are widely used to prevent fungal growth, but concerns about their potential health risks and regulatory restrictions have driven interest in natural antimicrobial agents, including essential oils.

Prevention of Mold Growth in Bakery and Dairy Products

Essential oils have been successfully applied in food preservation, particularly in bakery and dairy products, which are highly susceptible to mold contamination. Oregano oil (Origanum vulgare), rich in carvacrol and thymol, has demonstrated significant antifungal activity against Penicillium spp., Aspergillus spp. and Rhizopus spp., common spoilage fungi in bread and other baked goods (Gutiérrez et al., 2009). Similarly, rosemary oil (Rosmarinus officinalis), which contains carnosic acid and rosmarinic acid, has been effective in preventing mold growth in cheese and dairy products, extending their shelf life without altering sensory properties (Fernández-López et al., 2005).

Control of Postharvest Fungal Contamination in Fruits and Vegetables

Postharvest fungal infections significantly reduce the quality and shelf life of fresh fruits and vegetables. Essential oils such as clove oil, lemongrass oil and cinnamon oil have been tested as natural fumigants to prevent fungal decay caused by Botrytis cinerea (gray mold), Penicillium expansum (blue mold) and Alternaria spp. (Tzortzakis and Economakis, 2007). These essential oils work by inhibiting spore germination and mycelial growth, effectively reducing postharvest losses.

A study on citrus fruits found that clove essential oil (eugenol-rich) significantly reduced mold growth without affecting fruit quality, suggesting its potential as a natural alternative to synthetic fungicides like thiabendazole (Sharma et al., 2016).

Edible Coatings and Packaging Solutions

One of the most promising applications of essential oils in food preservation is their incorporation into edible coatings and biodegradable packaging materials. Essential oils can be integrated into chitosan-based films, alginate coatings, or nanoemulsions to provide controlled release of antifungal compounds, prolonging food shelf life while reducing microbial contamination (Seydim and Sarikus, 2006).

For example, a study demonstrated that thyme oil-loaded chitosan coatings effectively inhibited Aspergillus niger growth on fresh-cut apples, maintaining freshness and extending storage life (Perdones et al., 2012). Similarly, nanoencapsulated lemongrass oil has been used to inhibit Penicillium italicum in oranges, reducing fungal spoilage during storage (Patrignani et al., 2020).

CHALLENGES AND FUTURE DIRECTIONS

Despite their significant potential, the widespread adoption of essential oils (EOs) as antifungal agents faces several scientific and practical challenges. These include variability in composition, stability issues, sensory impact, regulatory hurdles and the need for optimized formulations. Addressing these challenges is crucial to fully harness the antifungal potential of EOs in medicine, agriculture and food preservation.

Variability in Composition and Standardization

The chemical composition of essential oils varies significantly depending on factors such as plant species, geographical origin, cultivation conditions, harvesting time and extraction methods (Bakkali et al., 2008). This variability affects their antifungal efficacy and safety, making standardization a key challenge. Future research should focus on developing quality control protocols, such as chemical fingerprinting, advanced chromatography techniques and metabolomic profiling, to ensure consistency in EO formulations.

Stability and Volatility

Essential oils are highly volatile and prone to degradation when exposed to light, heat and oxygen. This can reduce their efficacy over time, particularly in pharmaceutical and food preservation applications. To enhance stability, recent advancements have focused on encapsulation technologies, such as nanoemulsions, liposomes and polymer-based microcapsules, which protect active compounds and enable controlled release for prolonged antifungal activity (Sharifi-Rad et al., 2021).

Sensory Impact and Organoleptic Properties

Many essential oils have strong odors, flavors, or colors, which can impact their application in food preservation and consumer products. For instance, high concentrations of oregano or clove oil may impart undesirable taste and aroma to food products, limiting their practical use. Future research should explore strategies to mask or modulate EO sensory characteristics, such as blending with mild-flavored carriers, optimizing concentration levels, or using microencapsulation techniques to minimize sensory interference while maintaining antifungal potency.

Toxicity and Safety Concerns

While essential oils are generally recognized as natural and biodegradable, their safety at high concentrations remains a concern. Some EOs contain potent bioactive compounds, such as phenols, aldehydes and terpenes, which can cause cytotoxicity, skin irritation, or allergic reactions if not properly dosed (de Oliveira et al., 2019). Comprehensive toxicological studies, in vivo safety assessments and clinical trials are necessary to define safe concentration ranges, proper application methods and long-term effects in both medical and food-related uses.

Regulatory Approvals and Compliance

Although many essential oils are classified as Generally Recognized as Safe (GRAS) by regulatory agencies such as the FDA (U.S. Food and Drug Administration) and EFSA (European Food Safety Authority), their use in medicine and food preservation requires rigorous standardization, toxicity evaluations and regulatory approvals. The lack of clear guidelines and harmonized global regulations limits their commercial adoption. Future efforts should focus on establishing regulatory frameworks, conducting clinical validation studies and ensuring compliance with Good Manufacturing Practices (GMP) to facilitate their safe integration into mainstream industries.

Synergistic Formulations and Combination Strategies

To enhance the antifungal efficacy of essential oils while reducing potential toxicity and resistance development, researchers are exploring synergistic combinations with:

Conventional antifungal drugs (e.g., fluconazole, amphotericin B) to enhance therapeutic outcomes and reduce required dosages (Zore et al., 2011).

Natural bioactive compounds, such as antioxidants, polyphenols, or probiotics, to improve stability and bioavailability.

Other essential oils, leveraging complementary modes of action for broader-spectrum antifungal activity while mitigating individual EO limitations (e.g., oregano and thyme oils in combination).

These synergistic approaches hold promise for developing novel, multi-target antifungal formulations with improved efficacy and safety profiles.

METHODS FOR STUDYING ANTIFUNGAL ACTIVITY OF ESSENTIAL OILS

Essential oils (EOs) are widely studied for their antifungal properties due to their diverse bioactive compounds. Various in vitro and in vivo methods are used to evaluate their antifungal activity, focusing on fungal growth inhibition, cellular damage and metabolic disruption (Balouiri et al., 2016; Burt, 2004). Below are the commonly used techniques.

Agar Diffusion Method (Disc or Well Diffusion Assay)

Principle: The agar diffusion method evaluates the antifungal activity of EOs by measuring the zone of inhibition around EO-impregnated discs or wells in agar plates inoculated with fungal spores. The size of the inhibition zone reflects the antifungal potential of the EO being tested (CLSI, 2008).

Procedure: Prepare and sterilize fungal culture media such as Sabouraud Dextrose Agar (SDA) or Potato Dextrose Agar (PDA) before pouring it into sterile Petri dishes and allowing it to solidify (Hammer et al., 1999). Next, prepare a standardized fungal spore suspension, typically at a concentration of 1 × 10⁶ spores/mL and evenly spread it over the surface of the solidified agar using a sterile cotton swab (Nostro et al., 2007). To apply essential oils (EOs), use either the disc diffusion method—placing sterile paper discs (6 mm in diameter) impregnated with different EO concentrations on the agar surface—or the well diffusion method, which involves creating wells (6–8 mm in diameter) in the agar with a sterile cork borer and filling them with EO solutions at the desired concentrations (Balouiri et al., 2016). Incubate the plates at an appropriate temperature, usually between 25 and 30°C, for 48–72 hours. After incubation, measure the diameter of the inhibition zones, including the disc or well, in millimeters using a caliper or ruler (Burt, 2004).

Advantages

• Simple, rapid and cost-effective.

• Provides qualitative and semi-quantitative results.

• Suitable for preliminary screening of antifungal activity (CLSI, 2008).

Limitations

• Poor diffusion of EO in agar can lead to inconsistent results.

• EO volatility and solubility may affect reproducibility.

• Cannot determine minimum inhibitory concentration (MIC) directly (Nostro et al., 2007).

Broth Dilution Method for MIC and MFC Determination

Principle: The broth dilution method is used to determine the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of EOs against fungal pathogens. This method assesses fungal growth in liquid media containing serial dilutions of the EO, providing a quantitative measure of antifungal efficacy (Odds, 2003).

Procedure: Prepare serial dilutions of the essential oil (EO) in broth media such as RPMI-1640 or Sabouraud Dextrose Broth (CLSI, 2008). Standardize the fungal suspension to approximately 1 × 10⁵ CFU/mL and add the fungal inoculum to each EO dilution (Espinel-Ingroff and Pfaller, 2007). Incubate the samples at a temperature of 25–37°C for 24–48 hours, depending on the fungal species (Rex et al., 1993). Determine the minimum inhibitory concentration (MIC) as the lowest EO concentration that shows no visible growth (Meletiadis et al., 2001). For minimum fungicidal concentration (MFC) determination, subculture samples from wells at MIC and higher concentrations onto fresh agar plates, where the MFC is defined as the lowest EO concentration that kills ≥99.9% of the fungal population (CLSI, 2008).

Poisoned Food Technique (Agar Incorporation Method)

Principle: This method involves incorporating EOs into agar media before it solidifies, allowing direct interaction between the EO and the fungal mycelium. Fungal growth is then assessed by measuring the reduction in colony diameter compared to control conditions (Pandey et al., 2014).

Procedure: Prepare the agar media by incorporating varying essential oil (EO) concentrations into it (da Cruz Cabral et al., 2013). Once prepared, pour the media into Petri dishes and allow it to solidify. After solidification, inoculate the center of each agar plate with a fungal disc (Cavalcanti et al., 2013). Incubate the plates at a temperature of 25–30°C for several days. Finally, measure the radial growth of fungal colonies and calculate the percentage of inhibition (Mota et al., 2017).

Biochemical and Molecular Analysis (Flow Cytometry, qPCR, FTIR, etc.)

Principle: Advanced techniques provide critical insights into the molecular mechanisms underlying the antifungal activity of EOs. These methods help elucidate the specific interactions between EOs and pathogens at a molecular level (Tian et al., 2012; Dambolena et al., 2016).

Common Techniques

• Flow Cytometry: Used to assess fungal cell viability and apoptosis markers (Faleiro, 2010).

• qPCR: Evaluates changes in gene expression related to fungal stress responses (Barbosa et al., 2018).

• FTIR: Detects biochemical alterations in fungal cells following EO exposure (Batista et al., 2016).

CONCLUSION

Essential oils (EOs) present a promising and sustainable alternative to conventional antifungal agents, with diverse applications in medicine, agriculture and food preservation. Their broad-spectrum activity, targeting multiple fungal pathways—including membrane disruption, ergosterol biosynthesis inhibition, oxidative stress induction, mitochondrial dysfunction and enzyme inhibition—underscores their potential as effective antifungal agents. Furthermore, their biodegradability and natural origin position them as environmentally friendly alternatives to synthetic antifungals.

Despite these advantages, several challenges must be addressed to facilitate the widespread adoption of EOs in clinical and industrial settings. Key limitations include variability in chemical composition, stability concerns, potential cytotoxicity at high concentrations and regulatory hurdles. Overcoming these barriers will require:

• Optimizing EO formulations to enhance consistency, stability and controlled release using advanced delivery systems such as nano-encapsulation and emulsification.

• Conducting in vivo studies and clinical trials to validate efficacy, safety and pharmacokinetics in medical applications.

• Exploring EO-drug synergy to improve antifungal effectiveness, reduce resistance and minimize side effects.

• Developing regulatory frameworks to standardize EO quality, safety and efficacy across medical, agricultural and food applications.

A particularly promising avenue is the synergistic combination of EOs with conventional antifungal drugs, which has demonstrated enhanced efficacy, reduced resistance potential and lower toxicity. Future research should focus on identifying optimal EO-drug pairings, elucidating their mechanisms of action and developing novel EO-based formulations—such as nano-encapsulated EO-drug hybrids—for targeted antifungal therapy.

In the food industry, EOs offer significant potential as natural preservatives, inhibiting spoilage fungi and extending shelf life while reducing dependence on synthetic preservatives. However, challenges related to their sensory impact, volatility and regulatory status must be addressed to facilitate their commercial integration.

Furthermore, integrating multiple antifungal testing methods is essential for obtaining a comprehensive understanding of EO efficacy and mechanisms of action. Techniques such as flow cytometry (for fungal cell viability and apoptosis markers), qPCR (for gene expression analysis), FTIR spectroscopy (for biochemical alterations) and microscopy methods (for structural changes) provide valuable insights into EO-induced fungal inhibition. Additionally, biofilm assays are crucial for evaluating EO effectiveness against biofilm-forming fungal pathogens, which exhibit greater resistance to treatments. Metabolomic profiling using techniques like gas chromatography-mass spectrometry (GC-MS) further enhances our understanding by analyzing metabolic shifts induced by EO exposure.

By leveraging a multi-method approach, researchers can achieve a deeper and more nuanced understanding of EO interactions with fungal pathogens, ultimately improving the accuracy and reliability of findings. This integrative research framework will help unlock the full potential of EOs as antifungal agents, paving the way for safer, more effective and eco-friendly solutions in healthcare, agriculture and food preservation.

REFERENCES

Ahmad A., Khan A., Akhtar F., Yousuf S., Xess I., Khan L.A. (2010). Effect of thymol and eugenol on Candida albicans biofilm formation and hyphal transition. PLoS ONE, 5: e12050.

Ahmad A., Khan A., Akhtar F., Yousuf S., Xess I., Khan L. A. (2010). Eugenol-rich clove oil inhibits virulence factors of Candida albicans and protects against systemic candidiasis in mice. Journal of Applied Microbiology, 109: 1808–1818.

Ahmad A., Khan A., Manzoor N., Khan L.A. (2010). Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Expert Opinion on Therapeutic Targets, 14: 405–422.

Bakkali F., Averbeck S., Averbeck D., Idaomar M. (2008). Biological effects of essential oils—A review. Food and Chemical Toxicology, 46: 446–475.

Balouiri M., Sadiki M., Ibnsouda S.K. (2016). Methods for in vitro evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis, 6: 71–79.

Biazzi E., Ceresa C., Saporiti C., Cadenas C., Conti S., Posteraro B. (2020). Synergistic interaction between thymol and amphotericin B against Cryptococcus neoformans. Journal of Fungi, 6: 284.

Biazzi E., Fracchiolla G., Cavicchini C. (2020). Synergistic effects of thymol with amphotericin B against Cryptococcus neoformans. Mycoses, 63: 231–237.

Burt S. (2004). Essential oils: Their antibacterial properties and potential applications in foods—a review. International Journal of Food Microbiology, 94: 223–253.

Camele I., Altieri L., De Martino L., Mazzarrino G. (2012). Chemical composition and in vitro antifungal activity of essential oils from Mediterranean plants against postharvest diseases of fruit. Journal of Food Protection, 75: 2035–2045.

Cavaleiro C., Pinto E., Gonçalves M.J., Salgueiro L. (2006). Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. Journal of Applied Microbiology, 100: 1333–1338.

Cavaleiro C., Salgueiro L., Gonçalves M.J. (2006). Antifungal activity of essential oils against Candida species: Recent developments. Current Medicinal Chemistry, 13: 2449–2455.

CLSI (2008). Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard (M27-A3). CLSI.

Daferera D.J., Ziogas B.N., Polissiou M.G. (2003). The effectiveness of plant essential oils on the growth of Botrytis cinerea, Fusarium sp. and Clavibacter michiganensis subsp. michiganensis. Crop Protection, 22: 39–44.

Da Silva C.F., Sene L., Morais M.M. (2021). Combination therapy of essential oils and antifungal drugs: A promising strategy to combat fungal resistance. Journal of Applied Microbiology, 130: 1532–1545.

De Castro R.D., de Souza T.M., Bezerra L.M.D., Ferreira G.L.S., de Brito Costa E.M.M., Cavalcanti A.L. (2015). Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved in oral infections. Journal of Applied Microbiology, 119: 928–938.

De Castro R.D., de Souza T.M., Bezerra L.M., Ferreira G.L., de Brito Costa E.M. (2015). Antifungal activity and potential mechanism of geraniol against Candida species. Mycoses, 58: 550–556.

De Oliveira J.R., da Cruz L.C.N., de Oliveira F.E., Camargo S. E.A. (2019). Essential oils as alternative antimicrobial agents in dentistry. Microbial Pathogenesis, 130: 198–208.

De Oliveira Lima E., de Oliveira Lima, I.O., de Oliveira Pereira F., de Medeiros F.D., de Souza E.L., Farias Filho D.E. (2017). Inhibitory effect of thymol and eugenol on the Candida albicans secreted aspartyl protease (SAP) gene family. Frontiers in Microbiology, 8: 2369.

Doke S.K., Raut J.S., Karuppayil S.M. (2014). Sensitization of Candida albicans biofilms to fluconazole by eugenol and ginger oil. Mycoses, 57: 541–550.

Fernández-López J., Zhi N., Aleson-Carbonell L., Pérez-Alvarez J.A., Kuri V. (2005). Antioxidant and antibacterial activities of natural extracts: Application in beef meatballs. Meat Science, 69: 371–380.

Gutiérrez J., Barry-Ryan C., Bourke P. (2009). Antimicrobial activity of plant essential oils using food model media: Efficacy, synergistic potential and interactions with food components. Food Microbiology, 26: 142–150.

Hammer K.A., Carson C.F., Riley T.V. (1999). Antimicrobial activity of essential oils and other plant extracts. Journal of Applied Microbiology, 86: 985–990.

Hammer K.A., Carson C.F., Riley T.V. (2004). Antifungal effects of tea tree oil on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. Journal of Antimicrobial Chemotherapy, 53: 1081–1085.

Hammer K.A., Carson C.F., Riley T.V. (2012). Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. Journal of Applied Microbiology, 95: 853–860.

Harris C.A. (2002). Synergistic interactions between essential oils and conventional antifungal agents. Journal of Antimicrobial Chemotherapy, 49: 1051–1056.

Harris R. (2002). Synergism between essential oil components and antibiotics. Phytotherapy Research, 16: 202–205.

Hyldgaard M., Mygind T., Meyer R.L. (2012). Essential oils in food preservation: Mode of action, synergies and interactions with food matrix components. Frontiers in Microbiology, 3: 12.

Kedia A., Prakash B., Mishra P.K., Dubey N.K. (2014). Antifungal and antiaflatoxigenic properties of Cinnamaldehyde and Cymene against fungal isolates from indoor air of houses. International Biodeterioration and Biodegradation, 87: 1–8.

Khan A., Ahmad A., Akhtar F. (2017). Mechanistic insights into synergy between eugenol and antifungal drugs in combating drug-resistant Candida species. Journal of Applied Microbiology, 122: 1458–1468.

Khan A., Ahmad A., Akhtar F. (2017). Synergistic effect of cinnamaldehyde and carvacrol with fluconazole against Candida strains. Journal of Medical Microbiology, 66: 417–426.

Khan M.S.A., Ahmad I., Cameotra S.S. (2017). Induction of programmed cell death in Candida albicans by eugenol and its synergy with fluconazole. Journal of Applied Microbiology, 123: 743–754.

Kim H.J., Park J.H., Lee J.H. (2019). Linalool inhibits Candida albicans biofilm formation and enhances the efficacy of micafungin. International Journal of Antimicrobial Agents, 54: 645–652.

Kouassi K.H.S., Meless A.H.B., Koffi A., Konan Y.L. (2012). Antifungal activity of thyme and oregano essential oils against Fusarium oxysporum f. sp. lycopersici. International Journal of Agricultural Research, 7: 242–248.

Kumar S., Shukla R. (2018). Essential oils as emerging antifungal agents: A review. Journal of Essential Oil Research, 30: 1–15.

Lemos J.A., Costa T.C., Pereira C.A. (2017). Polyenes and essential oils: A synergistic approach against Candida species. Medical Mycology, 55: 885–894.

Li X., Zhang Z., Xu L. (2018). Synergistic antifungal activity of citral and caspofungin against Aspergillus fumigatus. Fungal Biology, 122: 840–848.

Mertas A., Garbusińska A., Szliszka E., Jureczko A., Kowalska M., Król W. (2015). The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains. Biomed. Research International, 2015: 1–8.

Mith H., Maquet B., Remacle J. (2020). Echinocandins and essential oils: A promising combination to combat fungal infections. Pathogens, 9: 180.

Nazzaro F., Fratianni F., De Martino L., Coppola R., De Feo V. (2013). Effect of essential oils on pathogenic bacteria. Pharmaceuticals, 6: 1451–1474.

Nostro A., A. Marino, A.R. Blanco, L. Cellini, M. Di Giulio, F. Pizzimenti, A.S. Roccaro, G. Bisignano (2007). Effects of oregano, carvacrol and thymol on Candida albicans. Journal of Medical Microbiology, 56: 519–523.

Odds F.C. (2003). Antifungal agents: mechanisms of action. Trends in Microbiology, 11: 272–279.

Oliveira R.A., Lima C.S., Almeida M.T. (2019). Essential oils as alternative therapeutic agents in the treatment of fungal infections. Journal of Medical Microbiology, 68: 515–523.

Park M.J., Gwak K.S., Yang I., Kim K.W., Jeung E.B., Chang J.W. (2007). Antifungal activities of the essential oil from Cinnamomum cassia and its main component, cinnamaldehyde, against human pathogenic fungi. Journal of Microbiology and Biotechnology, 17: 1471–1477.

Patrignani F., Siroli L., Serrazanetti D.I., Braschi G., Lanciotti R. (2020). Use of lemongrass essential oil nanoemulsion for the control of Penicillium italicum in oranges. Food Control, 113: 107181.

Peralta M.A., da Silva S.L., Teixeira A.B. (2018). Reactive oxygen species (ROS)-mediated antifungal mechanisms of essential oils. Microbial Pathogenesis, 123: 409–417.

Pina-Vaz C., Rodrigues A.G., Pinto E. (2004). Synergistic antifungal activity of essential oils with conventional antifungal agents. European Journal of Clinical Microbiology and Infectious Diseases, 23: 106–112.

Pinto E., Vale-Silva L., Cavaleiro C., Salgueiro L. (2009). Antifungal activity of clove essential oil and its major compound eugenol against Candida, Aspergillus and dermatophyte species. Journal of Medical Microbiology, 58: 1454–1462.

Sharifi-Rad J., Sureda A., Tenore G.C., Daglia M., Sharifi-Rad M., Valussi M., Iriti M. (2020). Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules, 25: 5216.

Shreaz S., Wani W.A., Behbehani J.M. (2016). Eugenol inhibits biofilm formation and restores antifungal susceptibility of drug-resistant Candida isolates. Mycoses, 59: 139–149.

Soković M., Glamočlija J., Marin P.D., Brkić D., van Griensven L. J. (2010). Antibacterial and antifungal activities of Thymus, Mentha and Satureja essential oils. Journal of Essential Oil Research, 22: 45–50.

Tian, J., Ban, X., Zeng, H., He, J., Chen, Y., and Wang, Y. (2012). Antifungal mechanism of Anethum graveolens essential oil against Candida albicans. PLoS One, 7: e30147.

Tian J., Ban X., Zeng H. (2012). Synergistic antifungal activity of essential oils and their major components against pathogenic fungi. Journal of Food Safety, 32: 1–8.

Tripathi P., Dubey N.K. (2004). Exploitation of natural products as an alternative strategy to control postharvest fungal rotting of fruit and vegetables. Postharvest Biology and Technology, 32: 235–245.

Turgis M., Han J., Lacroix M. (2012). Antifungal activity of selected essential oils against fungal pathogens. Journal of Food Science, 77: M527–M534.

Zore G.B., Thakre A.D., Jadhav S., Karuppayil S.M. (2011). Terpenoids inhibit Candida albicans growth by affecting membrane integrity and biofilm formation. Journal of Medical Microbiology, 60: 789–796.

Zore G.B., Thakre A.D., Karuppayil S.M. (2011). Synergistic activity of thymol and carvacrol with fluconazole against Candida albicans. Phytomedicine, 18: 1181–1188.